                         SEQUENCE LISTING

<110>  Tolero Pharmaceuticals, Inc.
       Siddiqui-Jain, Adam
        
<120>  Deuterated Alvocidib and Alvocidib Prodrugs

<130>  910208.443WO

<150>  62/688,140
<151>  2018-06-21

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  1

Arg Pro Glu Ile Trp Met Thr Gln Gly Leu Arg Arg Leu Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  2
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  2

Arg Pro Glu Ile Trp Leu Thr Gln Ser Leu Gln Arg Leu Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  3
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  3

Arg Pro Glu Ile Trp Leu Thr Gln His Leu Gln Arg Leu Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  4
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  4

Arg Pro Glu Ile Trp Met Gly Gln Gly Leu Arg Arg Leu Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  5
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  5

Arg Pro Glu Ile Trp Leu Gly Gln Ser Leu Gln Arg Leu Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  6
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  6

Arg Pro Glu Ile Trp Leu Gly Gln His Leu Gln Arg Leu Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  7
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  7

Arg Pro Glu Ile Trp Ile Thr Gln Glu Leu Arg Arg Ile Gly Asp Glu 
1               5                   10                  15      


Phe Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  8
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  8

Arg Pro Glu Ile Trp Met Thr Gln Glu Leu Arg Arg Ile Gly Asp Glu 
1               5                   10                  15      


Phe Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  9
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  9

Arg Pro Glu Ile Trp Ile Thr Gln Gly Leu Arg Arg Ile Gly Asp Glu 
1               5                   10                  15      


Phe Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  10
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  10

Arg Pro Glu Ile Trp Ile Thr Gln Glu Leu Arg Arg Leu Gly Asp Glu 
1               5                   10                  15      


Phe Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  11
<211>  23
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 binding domain

<400>  11

Arg Pro Glu Ile Trp Ile Thr Gln Glu Leu Arg Arg Ile Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  12
<211>  11
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TAT translocation domain

<400>  12

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  13
<211>  16
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  ANT translocation domain

<400>  13

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  14
<211>  37
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 profiling peptide

<400>  14

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Gly Gly Arg Pro 
1               5                   10                  15      


Glu Ile Trp Met Thr Gln Gly Leu Arg Arg Leu Gly Asp Glu Ile Asn 
            20                  25                  30          


Ala Tyr Tyr Ala Arg 
        35          


<210>  15
<211>  37
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  MCL-1 profiling peptide

<400>  15

Arg Pro Glu Ile Trp Met Thr Gln Gly Leu Arg Arg Leu Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg Gly Gly Gly Tyr Gly Arg Lys Lys Arg 
            20                  25                  30          


Arg Gln Arg Arg Arg 
        35          


